Comparative effectiveness of long-acting antipsychotics: issues and challenges from a pragmatic randomised study.

Although long-acting antipsychotics are widely used in individuals with psychotic disorders, it is unclear which long-acting preparation should be considered as first-line treatment in clinical practice. In this commentary, the main strengths and weaknesses of a recently published pragmatic randomised study comparing long-acting paliperidone palmitate v. long-acting haloperidol decanoate are briefly analysed.

RCT Entities:   Population Interventions Outcomes